chevron_leftBack
As of 19 June 2026, NovMetaPharma Co., Ltd. has a market cap of $70.72M USD, ranking #27988 globally and #1459 in South Korea.
It ranks #2527 in the Healthcare sector, and #905 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$70.72MUSD
109.02B KRW
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 1.3% | -1.1% | 1.3% | -4.7% | -44% | -29% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
229500
(주)노브메타파마
ISIN: KR7229500004
Shares Out.:
Shares Outstanding:
12.841M1
Shares Float:
10.26M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
8,100 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 0126Z0
|
$9.02B
13K%
13.91T KRW
|
-
|
|
KRX: 000250
|
$6.68B
9K%
10.3T KRW
|
1958.1
|
|
KRX: 326030
|
$5.17B
7K%
7.97T KRW
|
29.9
|
|
KRX: 298380
|
$4.9B
7K%
7.55T KRW
|
-
|
|
KRX: 000100
|
$4.49B
6K%
6.92T KRW
|
35.9
|
|
KRX: 141080
|
$4.38B
6K%
6.76T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
1M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
774K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
510K%
|
97.4
|
|
SIX: RO
|
$321.45B
454K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$287.52B
406K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.59B
388K%
218.9B CHF
|
20.5
|
chevron_leftBack